09:34:32 EDT Thu 24 May 2018
Enter Symbol
or Name

Shell Summary
Symbol C : *MKTSHEL
Recent Sedar Documents

Shell Summary for Dec. 11, 2012

2012-12-11 17:57 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell two points to 1,183 Tuesday, another slow day for the Canadian shell sector. Patrick Wong, a shell-maker from Saskatchewan, has found a new (to him) qualifying transaction for his Pacific-Link Capital Inc. (PCL).

Pacific-Link plans to roll back its shares 1:2 and then issue an unstated number of shares for Eidam Diagnostics Corp., a purported medical device company owned by Bernard Armani, who is also Eidam's sole director. The company has a long, undistinguished history that began in 1975 when Werner Eidam built its only product, the CRT 2000 Thermographic System, a device that detects body temperature irregularities. There is a short promotional clip on YouTube about the CRT 2000, which looks like a product from the 1980s: "Doctors use a probe to touch 119 points on the body, a process that takes 10 minutes and is then repeated for accuracy, and then the data collected may be indicative of irregular body function." The company's vice-president of public relations, Shelley Leonhardt, says the product is meant for early detection of certain diseases. Without being specific, she claims the product has found irregularities five years before they would show up on a mammogram or an MRI.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2018 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.

Comments for this item are closed